Stacie Jones

UAMS College of Medicine Honors Stacie M. Jones, M.D., as Distinguished Faculty Scholar

By Tamara Robinson

The College of Medicine at the University of Arkansas for Medical Sciences (UAMS) honored Stacie M. Jones, M.D., as the 2022 Distinguished Faculty Scholar for her groundbreaking research into food allergies, her leading role in the development of the first FDA-approved oral immunotherapy drug for life-threatening peanut allergy in children, and her dedication to mentorship.

Susan Smyth, M.D., Ph.D., executive vice chancellor of UAMS and dean of the College of Medicine, presents the college’s 2022 Distinguished Faculty Scholar award to Stacie M. Jones, M.D.

Jones, a professor in the Department of Pediatrics, delivered the annual Faculty Scholar Lecture Dec. 8 in an auditorium filled with research team members, other faculty from the Department of Pediatrics and Division of Pediatric Allergy and Immunology, and colleagues from throughout the college and Arkansas Children’s. Jones has served in the division since 1994 and was division director in 2003-2019.

“I want to recognize you for all of the things you have done in your field and for UAMS and Arkansas Children’s, and for mentoring so many people here in the audience and across the college,” said Susan Smyth, M.D., Ph.D., executive vice chancellor of UAMS and dean of the college. “You truly have had a distinguished career, and we are so pleased that you are part of our college and cannot wait to see where you and your team are going next in your work.”

https://news.uams.edu/2022/12/16/uams-college-of-medicine-honors-stacie-m-jones-m-d-as-distinguished-faculty-scholar/

Arkansas Children’s Hospital co-led study finds promise for peanut-allergy sufferers

by Talk Business & Politics staff (staff2@talkbusiness.net) January 21, 2022 10:54 am

A newly released study indicated that childhood peanut allergies could be desensitized with oral immunotherapy treatments, and some children could achieve remission.

The clinical trial was co-led by Arkansas Children’s Research Institute (ACRI) and UAMS researcher Stacie Jones, M.D. The results were published Jan. 21 in the medical journal The Lancet.

The youngest trial participants and those who started with lower levels of peanut-specific antibodies were the most likely to be successful.

https://talkbusiness.net/2022/01/arkansas-childrens-hospital-co-led-study-finds-promise-for-peanut-allergy-sufferers/